Periorbital necrobiotic xanthogranuloma resolved with three years of systemic lenalidomide treatment
Authors:
Open Access
- 20 December 2024
- journal article
- case report
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 37, 102233
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Ulcerating necrobiotic xanthogranuloma: A clinical sign to reconsider progression from MGUS to multiple myelomaJAAD Case Reports, 2023
- Systemic therapy of necrobiotic xanthogranuloma: a systematic reviewOrphanet Journal of Rare Diseases, 2022
- Necrobiotic xanthogranuloma: a 30-year single-center experienceAnnals of Hematology, 2018
- Necrobiotic xanthogranuloma treated with lenalidomideClinical and Experimental Dermatology, 2017
- Necrobiotic xanthogranuloma associated with monoclonal gammopathy: successful treatment with lenalidomide and dexamethasoneAnnals of Hematology, 2016
- Necrobiotic xanthogranulomaInternational Journal of Dermatology, 2008
- Necrobiotic xanthogranuloma: long-term outcome of ocular and systemic involvementAmerican Journal of Ophthalmology, 2000
- Necrobiotic xanthogranuloma.1992
- Necrobiotic XanthogranulomaArchives of Dermatology, 1992
- Necrobiotic xanthogranuloma with paraproteinemiaJournal of the American Academy of Dermatology, 1980